Alishir B. Gamzaev

Alishir B. Gamzaev

Auto-generated profile, based on publicly available information

Alishir B. Gamzaev

Privolzhsky Research Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Creative surgery and oncology
Verified
Journal Article
Open access
PDF file
Soslan Taisumovich EnginoevSoslan Taisumovich Enginoev
Soslan Taisumovich Enginoev
ICI. I. Chernov
I. I. Chernov
RKRoman Komarov
Roman Komarov
VBV. A. Belov
V. A. Belov
VAV. B. Arutyunyan
V. B. Arutyunyan
AGA. B. Gamzaev
A. B. Gamzaev
Introduction. One of surgical methods for treatment of aortic valve (AV) pathology is Aortic Valve Neocuspidalization Ozaki procedure (AVNeo). Thus, according to the latest systematic review, freedom from reoperation within one, three, five years after AVNeo was 98%, 97% and 96%. Available references provide few descriptions of reoperations after AVNeo. Aim. To analyze the immediate results of AV reinterventions after AVNeo. Materials and methods. In the medium term, reinterventions after AVNeo were necessary for 11 patients (4.3%). The age of patients ranged from 26 to 69 years. 11 patients who underwent surgery included 6 males and 5 females. Four patients had class III-IV CHF, according to NYHA classification. Three patients had previously been operated on for infective endocarditis (IE), and five patients had bicuspid aortic valve. The duration of follow-up, from AVNeo surgery to reinterventions, ranged from 3 to 43 months. Results and discussion. All patients underwent an isolated AV intervention. The main causes of dysfunction were IE (six patients) and leaflet rupture in the commissural area (five patients). Seven patients underwent aortic valve replacement with mechanical valves, one patient — with aortic homograft valve, one patient — with tissue valve and two patients underwent valve repair. In the early postoperative period, one patient had bleeding with the development of cardiac tamponade and one patient had a haemorrhagic stroke. No patients had ARF, perioperative myocardial damage, sternal infection or permanent pacemaker implantation. Two patients died during the hospital period. Conclusions. AV reinterventions are associated with a high incidence of complications and deaths. Therefore, prevention of IE and commissure enhancement should reduce the frequency of repeated interventions, which is to be confirmed by prospective studies in large cohorts of patients.

29 June 2022 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
SFSergey A. Fedorov
Sergey A. Fedorov
AMAleksandr P. Medvedev
Aleksandr P. Medvedev
LTLada M. Tselousova
Lada M. Tselousova
MKMaksim N. Kudykin
Maksim N. Kudykin
VPVladimir V. Pichugin
Vladimir V. Pichugin
ГВГамаюнов Сергей Викторович
Гамаюнов Сергей Викторович
INTRODUCTION: Pulmonary embolism (PE) is one of the most threatening complications in patients with neurological and neurosurgical problems. The high epidemiological threshold values and mortality in the considered group of patients attracted the interest of researchers in the methods of early diagnosis and selection of methods of reperfusion of the pulmonary arterial bed. AIM: To analyze clinical and hemodynamic results of the surgical and endovascular treatment of PE of the high and intermediatehigh risks in the group of patients with neurological and neurosurgical problems. MATERIALS AND METHODS: This study involved 24 patients with PE of high and intermediate high-risks. The first group involved seven patients with neurosurgical problems who underwent thromboembolectomy from the main and lobular branches of the pulmonary artery in conditions of parallel perfusion of the artificial circulation. The duration of perfusion was 26.0 7.4 min. The second group consisted of 17 patients with acute hemorrhagic stroke, in whom endovascular mechanical fragmentation of thromboemboli was performed using a modified Pig-Tail type catheter introduced by puncture through the subclavian or jugular vein. The first clinical manifestations of PE appeared 4.78 2.02 days after the neurosurgical intervention and 8.45 2.6 days after the onset of stroke. The initial systolic pressure in the pulmonary artery was 67.24 5.15 mm Hg in the first group and 70.53 4.53 mm Hg in the second group. Both groups had American Society of Anesthesiologist physical status IV and V classes of surgical risk and Pulmonary Embolism Severity Index class V (130174 points). RESULTS: The hospital survival rates were 100% and 82.36% in the first and second groups, respectively (three lethal cases due to progressing right-ventricular failure in the first 18 h after the procedure). On discharge, signs of reverse remodeling of the right heart chambers and reduction of the mean and systolic pressure in the pulmonary artery to 21 2.16 and 31 4.12 mm Hg, respectively, were noted in the first group and to 46 5.23 and 57 3.16 mm Hg, respectively, in the second group. CONCLUSION: Surgical treatment of PE is effective and safe with predictable results. Endovascular catheter induced destruction of the thromboembolus substrate is an alternative to the surgical treatment of patients with a high-risk of open surgery and absolute contraindications for thrombolytic therapy.

1 January 2023 in Clinical and Experimental Surgery. Petrovsky journal
Verified
Journal Article
Open access
F(Federal Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation (Astrakhan)
Federal Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation (Astrakhan)
ICI.I. Chernov
I.I. Chernov
Soslan Taisumovich EnginoevSoslan Taisumovich Enginoev
Soslan Taisumovich Enginoev
UАU.K. Аbdulmedzhidova
U.K. Аbdulmedzhidova
AZA.A. Ziankou
A.A. Ziankou
AGA.B. Gamzaev
A.B. Gamzaev
Отдаленные результаты операции Росса у взрослых

19 February 2022 in Grekov's Bulletin of Surgery
Verified
Journal Article
Open access
PDF file
AGA. B. Gamzaev
A. B. Gamzaev
SFS. A. Fedorov
S. A. Fedorov
VCV. A. Chiginev
V. A. Chiginev
VPVladimir V. Pichugin
Vladimir V. Pichugin
VTV. V. Teplitskaya
V. V. Teplitskaya
SDS. E. Domnin
S. E. Domnin
The article presents a case of successful surgical treatment of pulmonary embolism in a patient with a high risk of early cardiac death on the background of paradoxical embolism complicated by acute cerebrovascular accident. Cryptogenic acute cerebrovascular accident in combination with severe progressive right ventricular failure on the background of pulmonary embolism causes serious difficulties in making decisions regarding treatment tactics in these patients. Intracardiac localization of thromboemboli, threatened by the development of recurrent pulmonary embolism, as well as paradoxical embolism, requires immediate implementation of a differential diagnostic complex aimed at verifying the pathophysiological mechanism of the disease, which largely determines the effectiveness of the treatment. The analysis of the available literature data, given in the work, as well as the analysis of the clinical case, make it possible to develop a tactical algorithm in this group of patients and to determine the indications for open heart surgery.

5 December 2024 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
BKB. K. Kadyraliev
B. K. Kadyraliev
VBV. A. Belov
V. A. Belov
AMA. V. Marchenko
A. V. Marchenko
VAV. B. Arutyunayan
V. B. Arutyunayan
ICI. I. Chernov
I. I. Chernov
Soslan Taisumovich EnginoevSoslan Taisumovich Enginoev
Soslan Taisumovich Enginoev
In aortic valve (AV) replacement surgery in patients with a narrow annulus fibrosus (AF), the likelihood of prosthesis-patient mismatch (PPM) is high. PPM, in turn, significantly affects the hemodynamic and functional capabilities of AV, morbidity and mortality in the postoperative period. The “gold standard” for the treatment of AV diseases is prosthetics with mechanical and biological prostheses. However, there are alternative methods, such as neocuspidalization of AV according to the S. Ozaki (AVNeo) method.Aim: To compare the immediate and medium-term results of AV prosthetics using the S. Ozaki (AVNeo) technique and AV prosthetics with a biological prosthesis in patients with a small aortic annulus.Material and Methods: A retrospective multicenter study of 309 patients with a narrow fibrous ring of the aortic valve (FR AV) who underwent surgery between February 2010 and December 2021 was conducted. Inclusion criteria: prosthetics of AV, FR AV = 21 mm, age 18 years and older. Exclusion criteria: left ventricle ejection fraction ≤ 40%, repeated interventions, mini-stop. 153 patients underwent Aveo and 156 patients underwent AV prosthetics using biological prostheses. After “pseudorandomization” (propensity score matching), 92 patients were selected: 46 patients in the AVNeo group and 46 patients in the biological prosthesis group. The primary endpoint was hospital mortality. Postoperative complications, transvalvular gradients, and medium-term outcomes (three-year overall survival and freedom from surgery on AV) were evaluated as secondary endpoints.Results. There was no statistically significant difference in the duration of surgery (275.9 ± 34.2 min in the AVNeo group and 285.8 ± 37 min in the bioprosthesis group, p < 0.4), artificial circulation (98 min in the AVNeo group and 115 min in the bioprosthesis group, p < 0.3), aortic compression (80 min in the AVNeo group and 93 min in the bioprosthesis group, p < 0.7). Hospital mortality among the studied patients did not differ: in the AVNeo group – 2 (4.3%) and 1 (2.2%) in the bioprosthesis group, p = 1.0. There were no significant differences in postoperative complications: wound surface infection (3 (6.5%) in the AVNeo group and 1 (2.2%) in the bioprosthesis group, p = 0.617), acute kidney injury (1 (2.2%) in the AVNeo group and 0 in the bioprosthesis group, p = 1.0), stroke ( 1 (2.2%) in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 1.0), resternotomy for bleeding (0 in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 0.495). Permanent pacemaker implantation was not required by any patient. There was also no statistically significant difference in the three-year overall survival and re–operation, in the AVNeo group it was 83% and 92.5% in the bioprosthesis group, p = 0.23; three-year freedom from re-operation was 96.4% in the AVNeo group and 97.1% in the bioprosthesis group, p = 0.27. However, peak and average gradients were statistically less after AVNeo surgery. The peak and average gradients after AVNeo were 12 and 6 mmHg, after prosthetics 32 and 20 mmHg, p < 0.001.Conclusions: There was no statistically significant difference in hospital mortality, postoperative complications, and three-year survival and re-operation. The values of the peak and average pressure gradient at discharge differed statistically significantly in favor of the AVNeo group.

14 January 2024 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
ICI. I. Chernov
I. I. Chernov
Soslan Taisumovich EnginoevSoslan Taisumovich Enginoev
Soslan Taisumovich Enginoev
AZA. A. Ziankov
A. A. Ziankov
SES. S. Ekimov
S. S. Ekimov
AGA. B. Gamzaev
A. B. Gamzaev
The Ross procedure has been shown to have excellent long-term outcomes. However, pulmonary autografts remain at risk of dilation in the long-term period. Therefore, the autologous inclusion technique (AIT) and the Dacron inclusion technique (DIT) have been developed. No direct comparison up to date has been reported of these two techniques.Aim: To compare immediate and medium-term results performing various modified techniques of the Ross operation.Material and Methods. The following retrospective study included 43 patients (AIT: 22; DIT: 21) aged 18 years and older with an aortic valve (AV) pathology who underwent modified Ross procedures (AIT and DIT) from January 2014 to December 2019, performed by a single surgeon. The main endpoints were: in-hospital mortality, postoperative AV pressure gradients, time of myocardial ischemia and cardiopulmonary bypass, postoperative complications (resternotomy due to bleeding, perioperative myocardial infarction, stroke, sternal infection, conduction disorder requiring implantation of a permanent pacemaker, acute renal failure requiring hemodialysis) and mid-term outcomes (freedom from reoperation, freedom from aortic dilatation ≥ 5 cm). The median follow-up period was 23 (12–68) months.Results. The main indication for surgery was aortic regurgitation in 32 patients (74.4%). Bicuspid aortic valve was diagnosed in 29 (67.4%) patients. There were 33 (76.7%) males with an average age of 40 ± 11.7 years. There were no lethal outcomes in both groups. There was also no significant difference in postoperative complications. The peak and mean gradients on the AV were significantly lower in the AIT group than in the DIT group (6 and 4 mmHg vs 8 and 7 mmHg, p = 0.04). Five-year overall survival, freedom from reoperation on AV and PV, and freedom from dilatation of the ascending aorta ≥ 5 cm after modified Ross operation were 97.4%, 100%, and 100%, respectively. There was no statistically significant difference between groups in terms of overall survival (p = 0.66).Conclusion. Both techniques, autologous inclusion and Dacron inclusion, provide excellent immediate and mid-term outcomes in terms of overall survival, freedom from reoperation and freedom from aortic dilation